Translocation-Related Sarcomas

Fredrik Mertens; Cristina R. Antonescu; Peter Hohenberger; Marc Ladanyi; Piergiorgio Modena; Maurizio D'Incalci; Paolo G. Casali; Massimo Aglietta; Thor Alvegård

doi:10.1053/j.seminoncol.2009.06.004

Translocation-Related Sarcomas

Fredrik Mertens, Cristina R. Antonescu, Peter Hohenberger, Marc Ladanyi, Piergiorgio Modena, Maurizio D'Incalci, Paolo G. Casali, Massimo Aglietta, Thor Alvegård

Research output: Contribution to journal › Article

Abstract

Sarcomas with chromosomal translocations represent only about one fourth of sarcoma diagnoses. However, like gastrointestinal stromal tumor (GIST), with its characteristic KIT or PDGFRA mutations, they are particularly interesting since they provide specific biological insights and mechanisms of action that may have an impact upon prognosis or therapy. These are mechanisms we are just beginning to exploit. In this section we will review the biology and clinical impact of translocation-associated sarcomas and review the clinical findings that have made a recent impact upon patients with these diverse diagnoses.

Original language	English
Pages (from-to)	312-323
Number of pages	12
Journal	Seminars in Oncology
Volume	36
Issue number	4
DOIs	https://doi.org/10.1053/j.seminoncol.2009.06.004
Publication status	Published - Aug 2009

Fingerprint

ASJC Scopus subject areas

Oncology
Hematology

Cite this

Mertens, F., Antonescu, C. R., Hohenberger, P., Ladanyi, M., Modena, P., D'Incalci, M., Casali, P. G., Aglietta, M., & Alvegård, T. (2009). Translocation-Related Sarcomas. Seminars in Oncology, 36(4), 312-323. https://doi.org/10.1053/j.seminoncol.2009.06.004

@article{3d95f8cdea0148e3928931311e7215b3,

title = "Translocation-Related Sarcomas",

abstract = "Sarcomas with chromosomal translocations represent only about one fourth of sarcoma diagnoses. However, like gastrointestinal stromal tumor (GIST), with its characteristic KIT or PDGFRA mutations, they are particularly interesting since they provide specific biological insights and mechanisms of action that may have an impact upon prognosis or therapy. These are mechanisms we are just beginning to exploit. In this section we will review the biology and clinical impact of translocation-associated sarcomas and review the clinical findings that have made a recent impact upon patients with these diverse diagnoses.",

author = "Fredrik Mertens and Antonescu, {Cristina R.} and Peter Hohenberger and Marc Ladanyi and Piergiorgio Modena and Maurizio D'Incalci and Casali, {Paolo G.} and Massimo Aglietta and Thor Alveg{\aa}rd",

year = "2009",

month = aug

doi = "10.1053/j.seminoncol.2009.06.004",

language = "English",

volume = "36",

pages = "312--323",

journal = "Seminars in Oncology",

issn = "0093-7754",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Translocation-Related Sarcomas

AU - Mertens, Fredrik

AU - Antonescu, Cristina R.

AU - Hohenberger, Peter

AU - Ladanyi, Marc

AU - Modena, Piergiorgio

AU - D'Incalci, Maurizio

AU - Casali, Paolo G.

AU - Aglietta, Massimo

AU - Alvegård, Thor

PY - 2009/8

Y1 - 2009/8

N2 - Sarcomas with chromosomal translocations represent only about one fourth of sarcoma diagnoses. However, like gastrointestinal stromal tumor (GIST), with its characteristic KIT or PDGFRA mutations, they are particularly interesting since they provide specific biological insights and mechanisms of action that may have an impact upon prognosis or therapy. These are mechanisms we are just beginning to exploit. In this section we will review the biology and clinical impact of translocation-associated sarcomas and review the clinical findings that have made a recent impact upon patients with these diverse diagnoses.

AB - Sarcomas with chromosomal translocations represent only about one fourth of sarcoma diagnoses. However, like gastrointestinal stromal tumor (GIST), with its characteristic KIT or PDGFRA mutations, they are particularly interesting since they provide specific biological insights and mechanisms of action that may have an impact upon prognosis or therapy. These are mechanisms we are just beginning to exploit. In this section we will review the biology and clinical impact of translocation-associated sarcomas and review the clinical findings that have made a recent impact upon patients with these diverse diagnoses.

UR - http://www.scopus.com/inward/record.url?scp=67949088340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67949088340&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2009.06.004

DO - 10.1053/j.seminoncol.2009.06.004

M3 - Article

C2 - 19664492

AN - SCOPUS:67949088340

VL - 36

SP - 312

EP - 323

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 4

ER -

Access to Document

10.1053/j.seminoncol.2009.06.004